Skip to Main Content
Walk To Defeat ALS

Search Our Site

Talk to Us

We're just a phone call or mouse click away. Find help here.

ALS Registry

Share Print

Stem Cells

Stem Cells

Overview

The discovery that human embryonic stem cells can be isolated and propagated in the lab with the potential of developing into all tissues of the body is a major medical breakthrough. But it has raised ethical concerns. Stem cells are also present in adults, scientists now find. If there were a way to stimulate resident stem cells to replace dying cells, the limitations of transplantation could be overcome, as well as the ethical issues.

For ALS, it is becoming evident that it is not only the motor neuron that is at risk in the disease but neighboring cells as well. Attempts to replace these cells are ongoing and may be more feasible than motor neuron replacement. In the immediate future, stem cells may be vehicles that can be sent to the damaged area and provide missing factors to help remaining cells survive. Available options to be explored, together with the challenges to making stem cell therapy a reality for ALS, are pushing this field forward rapidly, with continued commitment of funds and expertise.

Quick links:

What are stem cells?

Stem cells are cells that have the ability to divide for indefinite periods in culture and give rise to multiple specialized cell types. They can develop into blood, bone, brain, muscle, skin and other organs. Embryonic stem cells are undifferentiated cells that have the ability to form any adult cell.

What are the types of embryonic stem cells?

Human embryonic stem cells are derived from fertilized embryos less than a week old. When a sperm fertilizes an egg and creates a single cell, this cell has the potential to form a complete organism. In the first hours after fertilization, this cell divides into identical, so-called totipotent cells. After approximately four days, the cells start to specialize and form a hollow sphere of cells called a blastocyst.

The blastocyst has an outer layer of cells and a hollow inside.  Within the hollow is a cluster of cells called the inner cell mass. Cells from the inner cell mass can be used to develop pluripotent stem cell lines-- they can develop into any of the tissues that form the body.

Embryonic stem (ES) cells lines are pluripotent. Earlier studies focused on mouse ES cells (see Figure 2), however recently scientists have shown that they are able to isolate and propagate humanembryonic stem cells in culture. (see Figure 3).

Pluripotent stem cells undergo further specialization into multipotent stem cells that give rise to cells with a particular function. For example, multipotent stem cells in the brain give rise to different neuronal cell types and glia (Figure 2A and Figure 3).

The discovery that human embryonic stem cells can be isolated and propagated in culture with the potential of developing into all tissues of the body is a major medical breakthrough. However it has raised a great deal of ethical questions.

What are the potentials for stem cells?

Insult to the adult central nervous system is devastating because of the inability of these neurons to regenerate and form appropriate connections to restore function. The consequences of insults to the brain and spinal cord are not just a break in communication between healthy neurons and their target, but a cascade of events that can lead to cell death.

The discovery of stem cells that can differentiate into neurons has opened up new doors for potential brain "repair" either through stimulation of stem cells resident in adult brain, endogenous stem cells, or through transplantation methods. The promise of these cells for cellular therapy is driving this explosive field of research.

Human stem cell research could also dramatically change the way we develop drugs and test them for safety. New medications could initially be tested using human cell lines prior to going into clinical trials. In addition, human stem cells can be used to develop assays to screen novel chemical compounds. Using these cell lines, scientists can discover the molecular cues necessary to differentiate stem cells into various specialized cells.

Adult stem cells vs. embryonic stem cells

Stem cells are important in early human development, yet they persist into adulthood. The presence of bone marrow stem cells in adults has been known for a long time. These stem cells give rise to all cells of the blood system. More recently, stem cells have been discovered in the adult brain and spinal cord. There are several approaches now in human clinical trails that utilize adult stem cells (such as blood forming cells and cartilage forming cells).

However, because adult cells are already specialized, their potential to regenerate damaged tissue is more limited. Another limitation is their inability to proliferate in culture. Therefore, obtaining clinically significant amounts of adult stem cells may prove to be difficult.

Alternate sources of stem cells

An intriguing discovery is that bone marrow cells (which are able to develop into all the cells of the blood system) transplanted into mice can migrate into the brain and develop into cells that appear to be neurons. These studies suggest that bone marrow may be a readily available source of neural cells with the potential for treating neurological disorders that would overcome the ethical issues.

In addition cord blood as a source of stem cells for transplantation has been proposed and studies have been published using this approach in animal models. However these results are still somewhat controversial and further research needs to be done to determine whether these sources of stem cells will indeed be useful for therapeutic approaches in diseases such as ALS.

Adult stem cell research is important and should be done alongside embryonic stem cell research as both will provide valuable insights. Only through exploration of all types of stem cell research will scientists find the most efficient and effective ways to treat diseases.

The presence of endogenous stem cells in the adult brain and spinal cord may provide an alternative to transplantation, eliminating the issues of tissue rejection. If there were a way to stimulate resident stem cells to replace dying cells the limitations of transplantation could be overcome. Small biotech companies are pursuing this direction in the hope of finding therapeutic compounds that will do this. Further research into molecules and genes that govern cell division, migration and specialization is needed, ultimately leading to new drug targets and therapies for ALS.

What are the challenges facing "stem cell therapy" in ALS?

Despite encouraging data that transplanted fetal cells can survive over long periods of time in the damaged area, few studies have shown neurons making appropriate contact with their targets. A recent report demonstrating that modified embryonic stem cells can generate a large number of dopamine neurons, the neurons missing in Parkinson's disease. This study showed some functional recovery in an animal model of Parkinson's which is very encouraging.

In Parkinson's disease functional improvement is less dependent on appropriate neuronal connections. For ALS, motor neurons have a huge challenge to form connections with their target muscles over a very long distance, in adults up to a meter (about 3 feet) in length.

The mechanism of motor neuron death in ALS remains unclear. It is not certain that transplanted stem cells would be resistant to the same source(s) of damage that causes motor neurons to die. Stem cells may need to be modified to protect against the toxic environment. There is also the potential that cultured stem cells used in transplant medicine could face rejection by the body's immune system.

Current research efforts

October 18, 2010
Neuralstem, Inc. updated the progress of its ongoing Phase I human clinical trial of the company’s spinal cord stem cells in the treatment of ALS at Emory University in Atlanta, Georgia. The company announced that, after reviewing the safety data from the first six non-ambulatory patients, the trial’s Safety Monitoring Board has unanimously approved moving to the next group of ALS patients.  Read full story 

 


More in this Section

The ALS Association - 1275 K Street NW - Suite 250 - Washington, DC 20005
All content and works posted on this website are owned and copyrighted by The ALS Association. ©2010

Lou Gehrig® used with permission of the Rip Van Winkle Foundation / www.LouGehrig.com